Molecular Therapy: Nucleic Acids (Dec 2017)

Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR-181a2

  • Yanjie Cheng,
  • Zhuying Wei,
  • Shengsong Xie,
  • You Peng,
  • Yi Yan,
  • Dan Qin,
  • Shenghui Liu,
  • Yanling Xu,
  • Guangpeng Li,
  • Lisheng Zhang

DOI
https://doi.org/10.1016/j.omtn.2017.09.008
Journal volume & issue
Vol. 9, no. C
pp. 195 – 206

Abstract

Read online

Widely varied compounds, including certain plasticizers, hypolipidemic drugs (e.g., ciprofibrate, fenofibrate, WY-14643, and clofibrate), agrochemicals, and environmental pollutants, are peroxisome proliferators (PPs). Appropriate dose of PPs causes a moderate increase in the number and size of peroxisomes and the expression of genes encoding peroxisomal lipid-metabolizing enzymes. However, high-dose PPs cause varied harmful effects. Chronic administration of PPs to mice and rats results in hepatomegaly and ultimately carcinogenesis. Nuclear receptor protein peroxisome proliferator-activated receptor-α (Pparα) was shown to be required for this process. However, biological adaptations to minimize this risk are poorly understood. In this study, we found that miR-181a2 expression was induced by the Pparα agonist WY-14643. Moreover, exogenous expression of miR-181a-5p dramatically alleviated the cell toxicity caused by overactivation of Pparα. Further studies showed that miR-181a-5p directly targeted the Pparα 3′ untranslated region and depressed the Pparα protein level. This study identified a feedback loop between miR-181a-5p and Pparα, which allows biological systems to approach a balance when Pparα is overactivated.

Keywords